Sign inJoin waitlistJoin the waitlist

Sean Grimm

Section Chief · Rush University Medical Center

Credentials: · · ·

History

Rush University Medical Center
Present
Section of Neuro-Oncology · Rush University Medical Center
Present
Rush University Medical Center
Present

Memorial Sloan Kettering Cancer Center
2005–2006
Neurology
2002–2005
Weill Cornell Medical College
2001–2002
Univ of Texas Sch of Med at San Antonio
1997–2001

Research

Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final…
Journal of Clinical Oncology · 2013 · 387 citations
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report
Annals of Oncology · 2007 · First of 18 authors · 208 citations
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial
The Lancet Oncology · 2021 · 177 citations

Jeffrey Raizer
28 papers
Priya Kumthekar
14 papers · 1 as a fellow
James Chandler
13 papers
MC
Marc Chamberlain
12 papers
Kenji Muro
7 papers
Rimas Lukas
7 papers
Craig Horbinski
6 papers
David Schiff
6 papers
Karan Dixit
6 papers
LA
Lauren Abrey
5 papers
Sean Sachdev
5 papers
Vinai Gondi
5 papers

Clinical trials

A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
Principal investigator · Unknown · Phase 1, Phase 2
TransMolecular
2008–2010
Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
Principal investigator · Unknown · Phase 1
TransMolecular
2008–2010
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Site PI · Available
Northwest Biotherapeutics